Enalapril

- TRADE NAMES: Amprace; Apo-Enalapril; Enaladil; Enapren; Glioten; Innovace (Merck Sharpe & Dohme); Lexxel (AstraZeneca); Pres; Renitec; Reniten; Teczem (Sanofi-Aventis); Vaseretic (Valeant); Vasotec (Valeant); Xanef
- INDICATIONS: Hypertension, symptomatic congestive heart failure, asymptomatic left ventricular dysfunction
- CLASS: Angiotensin-converting enzyme (ACE) inhibitor, Antihypertensive, Vasodilator
- HALF-LIFE: 11 hours
Alcohol, Aldesleukin, Allopurinol, Alpha blockers, Alprostadil, Amifostine, Amiloride, Angiotensin II receptor antagonists, Antacids, Antidiabetics, Antihypertensives, Antipsychotics, Anxiolytics and hypnotics, Aprotinin, Azathioprine, Baclofen, Beta blockers, Calcium channel blockers, Clonidine, Conivaptan, Corticosteroids, Cyclosporine, CYP3A4 inducers, Deferasirox, Diazoxide, Diuretics, Eplerenone, Estrogens, Everolimus, General anesthetics, Gold & Gold Compounds, Grapefruit Juice, Heparins, Hydralazine, Hypotensives, Insulin, Levodopa, Lithium, MAO inhibitors, Metformin, Methyldopa, Methylphenidate, Minoxidil, Moxisylyte, Moxonidine, Nitrates, Nitroprusside, NSAIDs, Pentoxifylline, Phosphodiesterase 5 inhibitors, Potassium salts, Prostacyclin analogues, Quinine, Rituximab, Salicylates, Sirolimus, Spironolactone, Sulfonylureas, Tadalafil, Temsirolimus, Tizanidine, Tolvaptan, Triamterene, Trimethoprim
PREGNANCY CATEGORY: D
category C in first trimester; category D in second and third trimesters
Lexxel is enalapril and felodipine; Teczem is enalapril and diltiazem; Vaseretic is enalapril and hydrochlorothiazide.
Hydrochlorothiazide is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.
Contra-indicated in patients with a history of angioedema with or without previous ACE inhibitor treatment.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric